The main treatment methods for NSCLC-LM patients include radiotherapy (RT), systemic and intrathecal chemotherapy, molecular targeted therapies and first-generation EGFR tyrosine kinase inhibitors (TKIs). This evidence concerns the gene EGFR and non-small cell lung carcinoma.